MSH|^~\&|LAB|QUL||4827620|20051103111111||ORU^R01|20051103582711930000|P|2.3|||||||
PID|1||GP0788895|13193|TestLastName^TestFirstName||19970308|M||||||||||13193|||||||||||||
ORC|RE|13193|GP0788895||CM|||||||^NOT GIVEN^^||||||||
OBR|1|13193|GP0788895|88888^*REPORT COMMENTS^^88888^*REPORT COMMENTS|||20051102111000|||||||20051102014500||^NOT GIVEN^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103070700|||X|||||||||||||||||||
OBX|1|ST|88888^*REPORT COMMENTS^^88888^*REPORT COMMENTS^||DNR|||N|||X|||20051103070700|SC^^L|||
OBR|2|13193|GP0788895|9651^LIPID PROFILE^^9651^LIPID PROFILE|||20051102111000|||||||20051102014500||^NOT GIVEN^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103070700|||F|||||||||||||||||||
OBX|1|NM|30120^CHOLESTEROL, TOTAL^^30120^CHOLESTEROL, TOTAL^||181|mg/dL|<170|H|||F|||20051103070700|SC^^L|||
OBX|2|NM|30125^TRIGLYCERIDES^^30125^TRIGLYCERIDES^||138|mg/dL|30-104|H|||F|||20051103070700|SC^^L|||
OBX|3|NM|30126^VLDL CHOLESTEROL (CALCULATED)^^30126^VLDL CHOLESTEROL (CALCULATED)^||28|mg/dL|5 - 40|N|||F|||20051103070700|SC^^L|||
OBX|4|NM|30128^LDL CHOLESTEROL (CALCULATED)^^30128^LDL CHOLESTEROL (CALCULATED)^||107|mg/dL|0 - 129|N|||F|||20051103070700|SC^^L|||
OBX|5|NM|39405^CHOLESTEROL, HDL^^39405^CHOLESTEROL, HDL^||46|mg/dL|37-76|N|||F|||20051103070700|SC^^L|||
OBX|6|NM|39406^CHOLESTEROL/HDL RATIO^^39406^CHOLESTEROL/HDL RATIO^||3.9||SEE NOTE|N|||F|||20051103070700|SC^^L|||
NTE|1||Reference Range: AVE. RISK 4.5-6.4|
NTE|2||     CARDIAC RISK FACTOR:   BELOW AVERAGE RISK |
OBX|7|NM|39408^LDL/HDL RATIO^^39408^LDL/HDL RATIO^||2.33||SEE NOTE|N|||F|||20051103070700|SC^^L|||
NTE|1||Reference Range: AV.RISK 2.25-4.90|
NTE|2||                            AVERAGE RISK|
OBR|3|13193|GP0788895|50051^PROTHROMBIN TIME (PT)^^50051^PROTHROMBIN TIME (PT)|||20051102111000|||||||20051102014500||^NOT GIVEN^^|||||SC^Quest Diagnostics^3714 Northgate Boulevard^Sacramento^CA^95834|20051103070700|||F|||||||||||||||||||
OBX|1|NM|50051^PROTHROMBIN TIME (PT)^^50051^PROTHROMBIN TIME (PT)^||22.4|sec|9.0-12.0|H|||F|||20051103070700|SC^^L|||
NTE|1|| |
NTE|2||REFERENCE RANGE FOR PROTHROMBIN TIME IS A NORMAL RANGE AND DOES NOT|
NTE|3||APPLY TO PATIENTS ON ANTICOAGULANT THERAPY.|
NTE|4|| |
NTE|5||                                        ***NOTE NEW REFERENCE RANGE***|
OBX|2|NM|50062^INR^^50062^INR^||2.3|||H|||F|||20051103070700|SC^^L|||
NTE|1||INR REFERENCE INTERVAL FOR PATIENTS NOT|
NTE|2||ON ANTICOAGULANT THERAPY:                         0.9-1.1|
NTE|3|| |
NTE|4||SUGGESTED INR THERAPEUTIC RANGE FOR ORAL|
NTE|5||ANTICOAGULANT THERAPY |
NTE|6||ROUTINE THERAPY:                                  2.0-3.0|
NTE|7|| |
NTE|8||RECURRENT MYOCARDIAL INFARCTION|
NTE|9||OR MECHANICAL PROSTHETIC VALVES:                   2.5-3.5|
NTE|10||                                        ***NOTE NEW REFERENCE RANGE***|
